{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T17:43:28Z","timestamp":1777484608345,"version":"3.51.4"},"reference-count":48,"publisher":"SAGE Publications","license":[{"start":{"date-parts":[[2025,4,22]],"date-time":"2025-04-22T00:00:00Z","timestamp":1745280000000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2025,4,22]],"date-time":"2025-04-22T00:00:00Z","timestamp":1745280000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"funder":[{"name":"Collegium Medicum Nicolaus Copernicus University","award":["AKRS.480.3.511.2023"],"award-info":[{"award-number":["AKRS.480.3.511.2023"]}]}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Cancer Control"],"published-print":{"date-parts":[[2025,8]]},"abstract":"<jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>\n                      Currently, prostate cancer (PC) is the most common medical problem endangering men\u2019s health and life worldwide. We tested the association of detected germline variants in\n                      <jats:italic toggle=\"yes\">BRCA2<\/jats:italic>\n                      with PC risk and estimated their impact on the clinical course of the disease, including overall survival time, in Polish men with localized PC that qualified for radical prostatectomy (RP).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and Methods<\/jats:title>\n                    <jats:p>DNA of 97 PC patients from various age groups and with different disease stages was analyzed. Control DNA samples consisted of 100 male volunteers without PC that were age-matched to the study group. Next Generation Sequencing (NGS) and Sanger sequencing were used for variant detection.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Five rare variants of the\n                      <jats:italic toggle=\"yes\">BRCA2<\/jats:italic>\n                      gene were detected in single PC patients. There were four substitutions (c.8010G&gt;C, c.682-32A&gt;G, c.9257-75G&gt;C, c.516+17G&gt;C) and one deletion (c.6393_6396del). Among the detected variants, one was pathogenic, one was a variant of uncertain significance (VUS), and three were likely benign. The c.8010G&gt;C was a new variant. In the carrier of the c.6393_6396del pathogenic variant, PC was diagnosed at the T3 stage and the patient survived 48\u00a0months after PC confirmation (the date of biopsy).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>\n                      The\n                      <jats:italic toggle=\"yes\">BRCA2<\/jats:italic>\n                      c.6393_6396del pathogenic variant demonstrates an association with clinical features of the disease (GS and TNM) and shorter survival of patients with localized prostate cancer that qualified for RP. Additionally, our findings suggest that multi-organ cancer aggregation in a family, including prostate cancer aggregation in close relatives, and young age at cancer onset should be taken into consideration by clinicians as an indication to refer patients to molecular testing.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1177\/10732748251327720","type":"journal-article","created":{"date-parts":[[2025,4,23]],"date-time":"2025-04-23T00:38:58Z","timestamp":1745368738000},"update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":0,"title":["Clinical Significance of Germline Variants in the\n                    <i>BRCA2<\/i>\n                    Gene and Their Association With Prostate Cancer Risk in Polish Men: A Case-Control Study"],"prefix":"10.1177","volume":"32","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2201-6148","authenticated-orcid":false,"given":"Marta","family":"Heise","sequence":"first","affiliation":[{"name":"Nicolaus Copernicus University in Toru\u0144"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Piotr","family":"Jarzemski","sequence":"additional","affiliation":[{"name":"Jan Biziel University Hospital in Bydgoszcz"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julia","family":"Kuk","sequence":"additional","affiliation":[{"name":"Nicolaus Copernicus University in Toru\u0144"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","published-online":{"date-parts":[[2025,4,22]]},"reference":[{"key":"e_1_3_6_2_2","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-09-2871"},{"key":"e_1_3_6_3_2","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.2011.383"},{"key":"e_1_3_6_4_2","doi-asserted-by":"publisher","DOI":"10.14740\/wjon1191"},{"key":"e_1_3_6_5_2","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.10819"},{"key":"e_1_3_6_6_2","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21834"},{"key":"e_1_3_6_7_2","doi-asserted-by":"publisher","DOI":"10.3390\/genes12071034"},{"key":"e_1_3_6_8_2","doi-asserted-by":"publisher","DOI":"10.1002\/pros.23795"},{"key":"e_1_3_6_9_2","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2022.0476"},{"key":"e_1_3_6_10_2","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-05-4000"},{"key":"e_1_3_6_11_2","doi-asserted-by":"publisher","DOI":"10.3390\/ijms232113426"},{"key":"e_1_3_6_12_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1603144"},{"key":"e_1_3_6_13_2","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.30817"},{"key":"e_1_3_6_14_2","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.31316"},{"key":"e_1_3_6_15_2","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000031705"},{"key":"e_1_3_6_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cub.2009.02.018"},{"key":"e_1_3_6_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2011.03.041"},{"key":"e_1_3_6_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.tibs.2004.04.009"},{"key":"e_1_3_6_19_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.1102574"},{"key":"e_1_3_6_20_2","first-page":"608","article-title":"Mechanisms of resistance to PARP inhibitors - an evolving challenge in oncology","volume":"2","author":"Mweempwa A","year":"2019","unstructured":"Mweempwa A, Wilson MK. Mechanisms of resistance to PARP inhibitors - an evolving challenge in oncology. Cancer Drug Resist. 2019;2:608-617.","journal-title":"Cancer Drug Resist"},{"key":"e_1_3_6_21_2","first-page":"2662","article-title":"Roles of the PARP inhibitor in BRCA1 and BRCA2 pathogenic mutated metastatic prostate cancer: direct functions and modification of the tumor microenvironment","volume":"15","author":"Inoue T","year":"2023","unstructured":"Inoue T, Sekito S, Kageyama T, Sugino Y, Sasaki T. Roles of the PARP inhibitor in BRCA1 and BRCA2 pathogenic mutated metastatic prostate cancer: direct functions and modification of the tumor microenvironment. Gene. 2023;15:2662.","journal-title":"Gene"},{"key":"e_1_3_6_22_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.21.02112"},{"key":"e_1_3_6_23_2","doi-asserted-by":"publisher","DOI":"10.15537\/smj.2020.1.24759"},{"key":"e_1_3_6_24_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1706450"},{"key":"e_1_3_6_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.molonc.2011.07.001"},{"key":"e_1_3_6_26_2","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14194751"},{"key":"e_1_3_6_27_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.89.8.3367"},{"key":"e_1_3_6_28_2","unstructured":"Cybulski C Gliniewicz B Sikorski A et al. Hereditary prostate cancer: clinical genetics of cancers 2018. In: Lubi\u0144ski J ed. Poland: Print Group Sp. Z o.O:179-192."},{"key":"e_1_3_6_29_2","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2105-15-182"},{"key":"e_1_3_6_30_2","unstructured":"Li H. Aligning sequence reads clone sequences and assembly contigs with BWA-MEM. 2013. Preprint at. https:\/\/arxiv.org\/abs\/1303.3997"},{"key":"e_1_3_6_31_2","doi-asserted-by":"publisher","DOI":"10.1101\/gr.107524.110"},{"key":"e_1_3_6_32_2","doi-asserted-by":"crossref","unstructured":"Poplin R Ruano-Rubio V DePristo MA et al. Scaling accurate genetic variant discovery to tens of thousands of samples. 2018. Preprint at. https:\/\/www.biorxiv.org\/content\/10.1101\/201178v3","DOI":"10.1101\/201178"},{"key":"e_1_3_6_33_2","unstructured":"Garrison E Marth G. Haplotype-based variant detection from short-read sequencing. 2012. Preprint at. https:\/\/arxiv.org\/abs\/1207.3907"},{"key":"e_1_3_6_34_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-147-8-200710160-00010"},{"key":"e_1_3_6_35_2","doi-asserted-by":"publisher","DOI":"10.1038\/gim.2015.30"},{"key":"e_1_3_6_36_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2020.05.005"},{"key":"e_1_3_6_37_2","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.748"},{"key":"e_1_3_6_38_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2007.09.035"},{"key":"e_1_3_6_39_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2023.104738"},{"key":"e_1_3_6_40_2","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/91.15.1310"},{"key":"e_1_3_6_41_2","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-03-0604"},{"key":"e_1_3_6_42_2","doi-asserted-by":"publisher","DOI":"10.1136\/jmg.2004.028829"},{"key":"e_1_3_6_43_2","first-page":"1694","article-title":"Population BRCA1 and BRCA2 mutation frequencies and cancer penetrances: a kin-cohort study in Ontario, Canada","volume":"98","author":"Risch HA","year":"2006","unstructured":"Risch HA, McLaughlin JR, Cole DEC, et al. Population BRCA1 and BRCA2 mutation frequencies and cancer penetrances: a kin-cohort study in Ontario, Canada. Cancer. 2006;98:1694-1706.","journal-title":"Cancer"},{"key":"e_1_3_6_44_2","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-08-1822"},{"key":"e_1_3_6_45_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10689-011-9506-2"},{"key":"e_1_3_6_46_2","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.2014.428"},{"key":"e_1_3_6_47_2","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.29041"},{"key":"e_1_3_6_48_2","doi-asserted-by":"publisher","DOI":"10.3109\/0284186X.2015.1067714"},{"key":"e_1_3_6_49_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2014.10.022"}],"container-title":["Cancer Control"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/10732748251327720","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/10732748251327720","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/10732748251327720","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T14:23:33Z","timestamp":1777386213000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/10732748251327720"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,22]]},"references-count":48,"alternative-id":["10.1177\/10732748251327720"],"URL":"https:\/\/doi.org\/10.1177\/10732748251327720","relation":{"has-review":[{"id-type":"doi","id":"10.1177\/10732748251327720\/v1\/review2","asserted-by":"object"},{"id-type":"doi","id":"10.1177\/10732748251327720\/v1\/decision1","asserted-by":"object"},{"id-type":"doi","id":"10.1177\/10732748251327720\/v1\/review1","asserted-by":"object"},{"id-type":"doi","id":"10.1177\/10732748251327720\/v2\/review1","asserted-by":"object"},{"id-type":"doi","id":"10.1177\/10732748251327720\/v2\/response1","asserted-by":"object"},{"id-type":"doi","id":"10.1177\/10732748251327720\/v2\/decision1","asserted-by":"object"}]},"ISSN":["1073-2748","1526-2359"],"issn-type":[{"value":"1073-2748","type":"print"},{"value":"1526-2359","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,22]]},"article-number":"10732748251327720"}}